Compare VRDN & VSECU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRDN | VSECU |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | 1600 |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2014 | N/A |
| Metric | VRDN | VSECU |
|---|---|---|
| Price | $16.89 | $49.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $35.46 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 45.6K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $279.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.07 | $38.45 |
| 52 Week High | $34.29 | $65.93 |
| Indicator | VRDN | VSECU |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 48.34 |
| Support Level | $15.68 | $45.92 |
| Resistance Level | $19.54 | $65.35 |
| Average True Range (ATR) | 0.86 | 4.74 |
| MACD | 0.79 | 0.25 |
| Stochastic Oscillator | 54.11 | 57.03 |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.